Adoptive tumor immunotherapy in mice as an adjunct to whole-body x-irradiation and chemotherapy. A review.
D000818:Animals; D000951:Antigens, Neoplasm; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D002066:Busulfan / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D005622:Friend murine leukemia virus / Q000276:immunology; D006087:Graft vs Host Reaction; D006649:Histocompatibility Antigens; D007111:Immunity, Cellular; D007112:Immunity, Maternally-Acquired; D007167:Immunotherapy; D007938:Leukemia / Q000276:immunology / Q000532:radiotherapy; D008223:Lymphoma / Q000188:drug therapy / Q000276:immunology / Q000532:radiotherapy; D051379:Mice; D008979:Moloney murine leukemia virus / Q000276:immunology; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000628:therapy*; D012509:Sarcoma / Q000188:drug therapy / Q000276:immunology / Q000532:radiotherapy; D013154:Spleen / Q000276:immunology; D014184:Transplantation, Homologous
D000951:Antigens, Neoplasm; D006649:Histocompatibility Antigens; D003520:Cyclophosphamide; D002066:Busulfan